Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of JAK2V617F mutation with thrombosis in Indian patients with Philadelphia negative chronic myeloproliferative neoplasms.

Indian journal of pathology & microbiology - 1 Jan 2000

Singh Kanwaljeet, Sazawal Sudha, Chhikara Sunita, Mahapatra Manoranjan, Saxena Renu

Abstract excerpt

BACKGROUND: : It is still a matter of debate regarding the association of JAK2V617F mutation with thrombosis in BCR-ABL negative CMPN patients. The role of JAK2V617F mutation in increasing the thrombotic risk in CMPNs is yet unequivocal. AIMS: : To clarify the contribution of JAK2V617F mutation in thrombosis in CMPN patients. SETTINGS AND DESIGN: This retrospective study was done to evaluate role of JAK2V617F...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Thrombosis

Share to Young Adult

Source

Identifiers

PMID: 30004057
DOI: 10.4103/IJPM.IJPM_781_17

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of JAK2V617F mutation with thrombosis in Indian patients with Philadelphia negative chronic myeloproliferative neoplasms.PMID 30004057Read ↗

JAK2 mutation and thrombosis in the myeloproliferative neoplasms.Semantic proximity Read ↗

Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms.Semantic proximity Read ↗

Molecular biomarkers of thrombosis in myeloproliferative neoplasms.Semantic proximity Read ↗

JAK2 mutation-related disease and thrombosis.Semantic proximity Read ↗

JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms.Semantic proximity Read ↗

Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision OncologySemantic proximity Read ↗

[Correlative study between JAK2 mutation and thrombosis in patients with myeloproliferative neoplasm].Semantic proximity Read ↗

[Thrombosis in myeloproliferative neoplasms].Semantic proximity Read ↗

Correlative study between the JAK2V617F mutation and thrombosis in patients with myeloproliferative neoplasm.Semantic proximity Read ↗

The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective.Semantic proximity Read ↗

Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms.Semantic proximity Read ↗

Clinical insights into the origins of thrombosis in myeloproliferative neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.